Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas

Journal of Clinical Oncology 2026

View at publisher
Authors: Jaishri O'Neill Blakeley, Xiaobu Ye, Dan Gabriel Duda, Chris F. Halpin, Amanda L. Bergner, Alona Muzikansky, Vanessa L. Merker, Elizabeth Robins Gerstner, Laura Marie Fayad, Shivani Ahlawat, Michael A. Jacobs, Rakesh K. Jain
+4 more Christopher K. Zalewski, Eva Dombi, Brigitte C. Widemann, Scott Randall Plotkin
DOI: 10.1200/jco-26-00231
Cited by: 0

Fields of Study & Subjects

Meningioma and schwannoma management Neurofibromatosis and Schwannoma Cases Ear and Head Tumors

Publication details

Journal / source
Journal of Clinical Oncology
Volume
44
Issue
8
Pages
723–723
Publication date
10 February 2026
Language
EN